Analysis of molecular prognostic factors associated with tumor immune and stromal microenvironment in BEATRICE, an open-label phase 3 trial in early triple-negative breast cancer (eTNBC)

作者:Molinero L; Yu J; Li C; Deurloo R; Dent R A; Bell R; Brown J; Parmar M; Toi M; Suter T; Steger G; Pivot X; Mackey J; Jackisch C; Hall P; Hegde P; Bais C; Cameron D
来源:38th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2015-12-08 To 2015-12-12.
DOI:10.1158/1538-7445.SABCS15-S1-01
  • 出版日期2016-2-15
  • 单位迪肯大学